SIGLEC8 and asthma: Previous work on Siglec‐F and Siglec‐8 has shown that antibody engagement of these receptors causes a pro‐apoptotic response in eosinophils, making them a potential drug target for asthma (Zimmermann et al, 2008; Kiwamoto et al, 2012).